Richard Giles Net Worth

The estimated Net Worth of Richard B Giles is at least $111 dollars as of 18 January 2013. Mr. Giles owns over 50,417 units of Ampio Pharmaceuticals Inc stock worth over $111 and over the last 13 years he sold AMPE stock worth over $0. In addition, he makes $0 as Independent Director at Ampio Pharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Giles AMPE stock SEC Form 4 insiders trading

Richard has made over 1 trades of the Ampio Pharmaceuticals Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 50,417 units of AMPE stock worth $116,967 on 18 January 2013.

The largest trade he's ever made was exercising 50,417 units of Ampio Pharmaceuticals Inc stock on 18 January 2013 worth over $116,967. On average, Richard trades about 1,939 units every 0 days since 2011. As of 18 January 2013 he still owns at least 50,417 units of Ampio Pharmaceuticals Inc stock.

You can see the complete history of Mr. Giles stock trades at the bottom of the page.

Richard Giles biography

Richard B. Giles serves as Independent Director of the Company. Mr. Giles, CPA, has served as a member of our Board since August 2010. Mr. Giles is the Chief Financial Officer (“CFO”) and Treasurer of Ludvik Electric Co., an electrical contractor headquartered in Lakewood, Colorado, a position he has held since 1985. Ludvik Electric is a private electrical contractor that has completed electrical contracting projects throughout the United States, South Africa and Germany. As CFO and Treasurer of Ludvik Electric, Mr. Giles oversees accounting, risk management, financial planning and analysis, financial reporting, regulatory compliance, and tax-related accounting functions. He serves also as the trustee of Ludvik Electric Co.’s 401(k) plan. Prior to joining Ludvik Electric, Mr. Giles was an Audit Partner for three years with Higgins Meritt & Company, then a Denver, Colorado CPA firm, and during the preceding nine years he was an Audit Manager and a member of the audit staff of Price Waterhouse, one of the legacy firms which now comprises PricewaterhouseCoopers. While with Price Waterhouse, Mr. Giles participated in a number of public company audits, including one for a leading computer manufacturer. Mr. Giles received a B.S. degree in accounting from the University of Northern Colorado. He is a member of the American Institute of Certified Public Accountants, Colorado Society of Certified Public Accountants, and Construction Financial Management Association.

How old is Richard Giles?

Richard Giles is 70, he's been the Independent Director of Ampio Pharmaceuticals Inc since 2010. There are 2 older and 8 younger executives at Ampio Pharmaceuticals Inc. The oldest executive at Ampio Pharmaceuticals Inc is Philip Coelho, 75, who is the Independent Director.

What's Richard Giles's mailing address?

Richard's mailing address filed with the SEC is C/O AMPIO PHARMACEUTICALS, INC., 373 INVERNESS PARKWAY, SUITE 200, ENGLEWOOD, CO, 80112.

Insiders trading at Ampio Pharmaceuticals Inc

Over the last 13 years, insiders at Ampio Pharmaceuticals Inc have traded over $202,762 worth of Ampio Pharmaceuticals Inc stock and bought 377,748 units worth $116,063 . The most active insiders traders include Philip H Coelho, Joshua R. Disbrow, eJ Kevin Buchi. On average, Ampio Pharmaceuticals Inc executives and independent directors trade stock every 192 days with the average trade being worth of $74. The most recent stock trade was executed by J Kevin Buchi on 9 June 2023, trading 21,858 units of AMPE stock currently worth $6,339.

What does Ampio Pharmaceuticals Inc do?

ampio pharmaceuticals inc (ampe) is a biotechnology company located in 5445 dtc pkwy, greenwood village, colorado, united states.

Complete history of Mr. Giles stock trades at Ampio Pharmaceuticals Inc

Ampio Pharmaceuticals Inc executives and stock owners

Ampio Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Michael E. Macaluso,
  Founder, Chairman & CEO (Leave of Absence )
• Daniel G. Stokely CPA, CPA,
  CFO, Corp. Sec. & Treasurer
• Holli Cherevka,
  Chief Operating Officer
• Daniel Stokely,
  Chief Financial Officer, Treasurer, Secretary
• Michael Macaluso,
  Chairman of the Board, Chief Executive Officer
• Holli Cherevka,
  Pres & COO
• David Bar-Or,
  Director
• David Stevens,
  Independent Director
• Richard Giles,
  Independent Director
• Philip Coelho,
  Independent Director
• Laura Goldberg,
  VP of Quality and Regulatory Operations
• April Ramirez,
  Clinical Trial Mang.
• Lane Hapke,
  VP of Manufacturing Operations
• Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D.,
  Chief Medical Officer
• Michael A. Martino,
  CEO & Chairman
• Michael A Martino,
  CEO
• J Kevin Buchi,
  Director
• Vaughan Lennox Clift,
  Chief Regulatory Affairs
• Gregory A Gould,
  Chief Financial Officer
• Iii Thomas E. Chilcott,,
  Chief Financial Officer
• Dan Stokely,
  CFO
• Mark D Mc Gregor,
  Chief Financial Officer
• Joshua R. Disbrow,
  Chief Operating Officer
• Elizabeth Varki Jobes,